₹175.27
+₹3.22 (+1.87%)
Closed · As of 26 Aug 3:30 pm
Mkt Cap
₹2,697 Cr
P/E
167.04
ROE
1.46%
ROCE
2.66%
About Dishman Carbogen Amcis Ltd
Dishman Carbogen Amcis is engaged in Contract Development and Manufacturing Organisation (CDMO) and manufacture and supply of marketable molecules such as specialty chemicals, vitamins& chemicals and disinfectants. The equity shares of Dishman Carbogen Amcis Limited are listed on National Stock Exchange of India Ltd.
Founded
2007
CEO
N/A
Employees
1,789
HQ
Gujarat, India
About Dishman Carbogen Amcis Ltd
Dishman Carbogen Amcis is engaged in Contract Development and Manufacturing Organisation (CDMO) and manufacture and supply of marketable molecules such as specialty chemicals, vitamins& chemicals and disinfectants. The equity shares of Dishman Carbogen Amcis Limited are listed on National Stock Exchange of India Ltd.
Founded:2007
CEO:N/A
Employees:1,789
HQ:Gujarat, India
Finished Products
1Sale of Products
₹615.43Cr2Business Support Services
₹36.66Cr3Other Operating Income
₹30.50Cr4Forex Gain on Forward Contract
₹18.09Cr5Sale of Raw Maerial
₹12.58Cr6Sale of Services
₹11.57Cr7Sale of Scrap
₹1.21Cr1–7 of 8
Raw Materials
1Raw Material Consumed
₹224.71CrPrice Performance & Market EventsPrice Performance
Loading chart data…
Key Metrics
Trading & valuation snapshot
52W High
₹322
52W Low
₹129
Volume419.63K
Avg VolumeN/A
Beta1.84
Dividend Yield0.00%
Key Financial Ratios
Profitability, leverage & efficiency at a glance
P/E Ratio
167.04x
Valuation
P/B Ratio
0.40x
Valuation
EPS
₹1.03
Valuation
Dividend Yield
0.00%
Valuation
ROE
1.46%
Profitability
ROCE
2.66%
Profitability
Revenue by Segment
Contribution & growth by business line
CRAMS
+15.1%77.0%
₹1,649.34 Cr
Vitamin-D, Bulk Drugs, Quats, Spec
+2.4%23.0%
₹491.35 Cr
Geographical Revenue Split
Domestic vs international exposure
Domestic
1.7%
International
98.3%
Rest of the world98.3%
India1.7%
Strategic Relations
Collaborations, joint ventures & subsidiaries
No collaborations data available.
Forensic Metrics
Financial health & earnings-quality indicators
Revenue Quality
N/A
Days Sales Outstanding
Leverage
0.46x
Debt-to-Equity
Earnings Quality
N/A
Cash Conversion Ratio
Efficiency
N/A
Asset Turnover
Earnings Quality
N/A
Accruals Ratio
Profitability
N/A
Gross Margin
Growth
4.0%
Sales Growth
These metrics are derived from available financial disclosures and market data. Use them together with company filings and qualitative analysis before making decisions.